|
US7285267B2
(en)
|
1997-01-14 |
2007-10-23 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6α & 6β
|
|
JP2001507937A
(en)
|
1997-01-14 |
2001-06-19 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
Tumor necrosis factor receptor 6α and tumor necrosis factor receptor 6β
|
|
US7063854B1
(en)
|
1998-09-30 |
2006-06-20 |
Corixa Corporation |
Composition and methods for WTI specific immunotherapy
|
|
US7329410B1
(en)
|
1998-09-30 |
2008-02-12 |
Corixa Corporation |
Compositions and method for WT1 specific immunotherapy
|
|
US7115272B1
(en)
|
1998-09-30 |
2006-10-03 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US7901693B2
(en)
|
1998-09-30 |
2011-03-08 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US7144581B2
(en)
|
2000-10-09 |
2006-12-05 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US7655249B2
(en)
|
1998-09-30 |
2010-02-02 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
|
WO2002008274A2
(en)
*
|
2000-07-21 |
2002-01-31 |
Millennium Pharmaceuticals, Inc. |
56939, a human acyl-coa thioesterase family member and uses thereof
|
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
KR100399982B1
(en)
*
|
2000-06-16 |
2003-11-13 |
학교법인고려중앙학원 |
Novel mouse CIA protein and CIA gene having anti-apoptotic activity as a selective inhibitor of CAD interacting with ASK1 and use thereof
|
|
CN1329031A
(en)
*
|
2000-06-19 |
2002-01-02 |
上海博德基因开发有限公司 |
Polypeptide-human RNA bindin 19 and polynucleotide for coding it
|
|
WO2002036808A2
(en)
*
|
2000-11-03 |
2002-05-10 |
Diadexus, Inc. |
Compositions and methods relating to prostate specific genes and proteins
|
|
US7431923B2
(en)
|
2005-01-03 |
2008-10-07 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7442777B2
(en)
|
2000-11-29 |
2008-10-28 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7534429B2
(en)
|
2000-11-29 |
2009-05-19 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
WO2002057460A2
(en)
|
2000-12-20 |
2002-07-25 |
Bristol-Myers Squibb Company |
Polynucleotides encoding human phosphatases
|
|
AU2002318112B2
(en)
|
2001-04-10 |
2007-12-06 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
WO2002083866A2
(en)
*
|
2001-04-17 |
2002-10-24 |
The Board Of Trustees Of The University Of Arkansas |
Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
|
|
US20030060410A1
(en)
*
|
2001-05-15 |
2003-03-27 |
North Shore Long Island Jewish Research Institute |
Use of HMG fragments as anti-inflammatory agents
|
|
CA2448253A1
(en)
*
|
2001-05-25 |
2002-11-28 |
Genset S.A. |
Human cdnas and proteins and uses thereof
|
|
US7157558B2
(en)
*
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
|
US7026121B1
(en)
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
WO2003004989A2
(en)
|
2001-06-21 |
2003-01-16 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
WO2003010198A1
(en)
*
|
2001-07-26 |
2003-02-06 |
Kenton Srl |
Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques
|
|
US7553494B2
(en)
|
2001-08-24 |
2009-06-30 |
Corixa Corporation |
WT1 fusion proteins
|
|
US7270960B2
(en)
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
US7504222B2
(en)
*
|
2001-10-31 |
2009-03-17 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
US7306919B1
(en)
*
|
2001-10-31 |
2007-12-11 |
Thornthwaite Jerry T |
Antigen-antibody cancer recognition system
|
|
WO2003104428A2
(en)
|
2002-01-21 |
2003-12-18 |
Vaccinex, Inc. |
Gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
|
WO2003068054A2
(en)
*
|
2002-02-13 |
2003-08-21 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health Services |
Identification of ovarian cancer tumor markers and therapeutic targets
|
|
CN1507491A
(en)
*
|
2002-02-19 |
2004-06-23 |
株式会社Bf研究所 |
Substances that interact with CGI-94 to promote apoptosis and inhibit apoptosis and screening methods thereof
|
|
EP2261368A1
(en)
|
2002-03-13 |
2010-12-15 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
|
WO2003093826A2
(en)
*
|
2002-04-29 |
2003-11-13 |
Clinigenetics |
Assays for identifying cholesterol - lowering molecules
|
|
AU2003278137A1
(en)
|
2002-06-20 |
2004-01-06 |
Bristol-Myers Squibb Company |
Identification and regulation of a g-protein coupled receptor, rai-3
|
|
US7851213B2
(en)
*
|
2002-07-03 |
2010-12-14 |
Sanofi Pasteur Limited |
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
|
|
AU2003246391A1
(en)
*
|
2002-07-08 |
2004-01-23 |
Bayer Healthcare Ag |
Regulation of human casein kinase i epsilon
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US20050175625A1
(en)
|
2002-07-12 |
2005-08-11 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US20090110702A1
(en)
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
|
AU2003258127A1
(en)
|
2002-08-06 |
2004-02-23 |
Diadexus, Inc. |
Compositions and methods relating to ovarian specific genes and proteins
|
|
ATE397098T1
(en)
*
|
2002-08-30 |
2008-06-15 |
Oncotherapy Science Inc |
METHOD FOR DIAGNOSTIC OVARIAN ENDOMETRIOSIS
|
|
AU2002951346A0
(en)
*
|
2002-09-05 |
2002-09-26 |
Garvan Institute Of Medical Research |
Diagnosis of ovarian cancer
|
|
ATE502051T1
(en)
|
2002-10-16 |
2011-04-15 |
Purdue Pharma Lp |
ANTIBODIES THAT BIND TO CELL-ASSOCIATED CA 125/0722P AND METHOD OF USE THEREOF
|
|
EP2364716A3
(en)
*
|
2002-11-08 |
2012-01-11 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
|
US8008003B2
(en)
|
2002-11-15 |
2011-08-30 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
|
EP1581641A4
(en)
*
|
2002-12-06 |
2006-11-15 |
Diadexus Inc |
COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
EP1597391B1
(en)
|
2003-02-20 |
2008-10-29 |
Genomic Health, Inc. |
Use of intronic rna to measure gene expression
|
|
UA87106C2
(en)
*
|
2003-03-19 |
2009-06-25 |
Байоджен Айдек Ма Інк. |
Nogo receptor binding protein
|
|
WO2005039382A2
(en)
|
2003-06-24 |
2005-05-06 |
Genomic Health |
Prediction of likelihood of cancer recurrence
|
|
ES2905579T3
(en)
|
2003-07-10 |
2022-04-11 |
Genomic Health Inc |
Expression profiling algorithm and test for prognosis of breast cancer relapse
|
|
JP4643450B2
(en)
|
2003-08-08 |
2011-03-02 |
株式会社ペルセウスプロテオミクス |
Cancer high expression gene
|
|
WO2005019258A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US7799518B2
(en)
*
|
2003-10-07 |
2010-09-21 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
CA2445743A1
(en)
|
2003-10-08 |
2005-04-08 |
The University Of British Columbia |
Methods for modulating neuronal responses
|
|
ATE498022T1
(en)
|
2003-12-23 |
2011-02-15 |
Genomic Health Inc |
UNIVERSAL DUPLICATION OF FRAGMENTED RNA
|
|
US7569662B2
(en)
|
2004-01-27 |
2009-08-04 |
Compugen Ltd |
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
|
|
US7667001B1
(en)
|
2004-01-27 |
2010-02-23 |
Compugen Ltd. |
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
|
|
EP2163650B1
(en)
|
2004-04-09 |
2015-08-05 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
JPWO2005097204A1
(en)
|
2004-04-09 |
2008-02-28 |
武田薬品工業株式会社 |
Cancer preventive / therapeutic agent
|
|
RS52593B
(en)
|
2004-06-24 |
2013-04-30 |
Biogen Idec Ma Inc. |
TREATMENT OF THE CONDITIONS CONCERNING DEMYELINIZATION
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
AU2005304878B2
(en)
|
2004-11-05 |
2010-07-08 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
|
JP5020088B2
(en)
|
2004-11-05 |
2012-09-05 |
ジェノミック ヘルス， インコーポレイテッド |
Predicting response to chemotherapy using gene expression markers
|
|
CA2593034A1
(en)
*
|
2004-12-09 |
2006-06-15 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods based upon the kinase haspin
|
|
WO2006108095A2
(en)
*
|
2005-04-06 |
2006-10-12 |
The University Of Maryland, Baltimore |
Serum biomarker for disease and methods of using same
|
|
WO2006121869A2
(en)
*
|
2005-05-05 |
2006-11-16 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating mood and anxiety disorders
|
|
NZ564762A
(en)
*
|
2005-05-26 |
2011-10-28 |
Univ Johns Hopkins |
Compositions and methods for the treatment or prevention of chemoresistant neoplasia
|
|
WO2007005733A2
(en)
*
|
2005-07-01 |
2007-01-11 |
Cornell Research Foundation, Inc. |
Novel peptides promoting neurite outgrowth
|
|
ES2434470T3
(en)
|
2005-07-08 |
2013-12-16 |
Biogen Idec Ma Inc. |
SP35 antibodies and their uses
|
|
CN103435683B
(en)
|
2006-06-16 |
2016-02-03 |
肿瘤疗法·科学股份有限公司 |
Cancer rejection antigen peptide from SPARC and the medicine containing this peptide
|
|
EP2067791A4
(en)
|
2006-10-06 |
2009-11-25 |
Takeda Pharmaceutical |
PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
|
|
US8128926B2
(en)
|
2007-01-09 |
2012-03-06 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
|
US7812002B2
(en)
*
|
2007-03-21 |
2010-10-12 |
Quark Pharmaceuticals, Inc. |
Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
|
|
CA2682132C
(en)
*
|
2007-03-29 |
2022-03-22 |
Fujirebio Diagnostics, Inc. |
Use of he4 for assessment of breast cancers
|
|
WO2008157383A1
(en)
*
|
2007-06-15 |
2008-12-24 |
Biosite Incorporated |
Methods and compositions for diagnosis and/or prognosis of ovarian cancer and lung cancer
|
|
EP2228457A1
(en)
*
|
2007-08-16 |
2010-09-15 |
Genomic Health, Inc. |
Gene expression markers of recurrence risk in cancer patients after chemotherapy
|
|
CA2701189C
(en)
*
|
2007-10-11 |
2017-05-16 |
Biogen Idec Ma Inc. |
Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell survival via administration of lingo-1 antagonists and trkb agonists
|
|
WO2009061500A1
(en)
*
|
2007-11-08 |
2009-05-14 |
Biogen Idec Ma Inc. |
Use of lingo-4 antagonists in the treatment of conditions involving demyelination
|
|
NZ586544A
(en)
|
2007-12-26 |
2012-07-27 |
Vaccinex Inc |
Anti-c35 antibody in combination with an ani-her2 antibody in cancer therapies and methods
|
|
WO2009144704A2
(en)
*
|
2008-04-15 |
2009-12-03 |
Quark Pharmaceuticals, Inc. |
siRNA COMPOUNDS FOR INHIBITING NRF2
|
|
AU2009269099B2
(en)
*
|
2008-07-09 |
2016-03-10 |
Biogen Ma Inc. |
Compositions comprising antibodies to LINGO or fragments thereof
|
|
CA2745849A1
(en)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
|
|
CN102482334A
(en)
*
|
2009-03-11 |
2012-05-30 |
阿布拉西斯生物科学有限责任公司 |
Sparc angiogenic domain and methods of use
|
|
US20120213744A1
(en)
|
2009-04-27 |
2012-08-23 |
Ottawa Hospital Research Institute |
Compositions and methods for modulating stem cells and uses thereof
|
|
US9220746B2
(en)
|
2009-06-04 |
2015-12-29 |
The University Of North Carolina At Chapel Hill |
Compounds and methods for treating bone disorders and controlling weight
|
|
AU2012321103B2
(en)
|
2011-09-16 |
2016-05-12 |
Ottawa Hospital Research Institute |
Wnt7a compositions and methods of using the same
|
|
JP2014527818A
(en)
*
|
2011-09-16 |
2014-10-23 |
フェイト セラピューティクス，インコーポレイテッド |
Wnt compositions and therapeutic uses of such compositions
|
|
WO2013155567A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Mat Malta Advanced Technologies Limited |
Sex determination genes
|
|
AU2013262934B2
(en)
|
2012-05-14 |
2018-02-01 |
Biogen Ma Inc. |
LINGO-2 antagonists for treatment of conditions involving motor neurons
|
|
EP3016968B1
(en)
*
|
2013-07-01 |
2019-06-26 |
Newsouth Innovations Pty Limited |
Diagnosis and treatment of autoimmune diseases
|
|
RS62529B1
(en)
|
2013-07-11 |
2021-11-30 |
Modernatx Inc |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
|
EP3112378B1
(en)
*
|
2014-02-26 |
2020-06-24 |
Tella, Inc. |
Wt1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
|
|
CA2973266A1
(en)
|
2015-01-08 |
2016-07-14 |
Biogen Ma Inc. |
Lingo-1 antagonists and uses for treatment of demyelinating disorders
|
|
WO2017070569A1
(en)
*
|
2015-10-23 |
2017-04-27 |
Oregon Health & Science University |
Compounds that bind macrophage migration inhibitory factor
|
|
US11639371B2
(en)
*
|
2016-02-17 |
2023-05-02 |
The Chinese University Of Hong Kong |
Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and methods for reducing polyQ-mediated toxicity in polyQ diseases
|
|
US10767164B2
(en)
|
2017-03-30 |
2020-09-08 |
The Research Foundation For The State University Of New York |
Microenvironments for self-assembly of islet organoids from stem cells differentiation
|
|
DE102018200518B4
(en)
*
|
2018-01-15 |
2023-09-14 |
Robert Bosch Gmbh |
Microfluidic device and method for its operation
|
|
CA3178965A1
(en)
|
2020-05-15 |
2021-11-18 |
Christian COBAUGH |
Messenger rna encoding cas9 for use in genome-editing systems
|
|
CN112557347B
(en)
*
|
2020-11-12 |
2023-10-24 |
渤海大学 |
Preparation and detection method of a chylo particle migration model in the mucus layer
|
|
GB202211117D0
(en)
*
|
2022-07-29 |
2022-09-14 |
Replay Holdings Llc |
Compositions and methods for non-immunogenecity
|